Development of Immunocompetence

Cell-mediated immunity begins developing during the third month of fetal growth. T cells migrate from the fetal thymus and settle in the skin, mouth lining, and digestive tract. These cells, including dendritic cells that serve as antigen-presenting cells, are essential for T cell activation and establishing immune competence early in development.

Maternal IgG antibodies are the only antibodies capable of crossing the placenta, providing passive immunity to the fetus. This maternal protection typically remains adequate throughout fetal development. However, if bacterial or viral infections overwhelm maternal defenses, the fetus may not be adequately protected despite receiving maternal IgG antibodies.

Early B cells are produced in the fetal liver and bone marrow beginning around the third month of development. These cells display IgM antibodies on their plasma membranes. While the fetus typically does not produce antibodies due to maternal IgG protection, limited fetal IgM production can occur after the fourth month if exposed to high pathogen levels.

ABO blood group incompatibilities are rare because anti-A and anti-B antibodies are IgM antibodies, which cannot cross the placenta. In contrast, Rh incompatibility involves IgG antibodies that can cross the placental barrier, making Rh incompatibility a more significant concern during pregnancy and delivery.

After birth, maternal IgG supply is cut off and rapidly declines in the infant's bloodstream during the first two months. Infants receive IgA antibodies through breast milk, but this does not fully replace lost maternal IgG protection. This decline leaves infants temporarily vulnerable to infections that maternal antibodies previously protected against.

After T cells depart from the fetal thymus, they populate lymphoid organs throughout the body. These cells establish immune surveillance networks essential for adaptive immunity. T cells continue to develop and mature in secondary lymphoid tissues, gradually building the cellular immune response capacity needed for adult-level immunocompetence.

From birth to age 12, children encounter new antigens and gradually build memory B cells, T cell counts, and antibody levels characteristic of adults. This progressive immune development occurs as the infant's own immune system replaces declining maternal antibodies. Repeated antigen exposure and immune responses during childhood establish the robust immunological memory required for lifelong protection.